Coronary Artery Lesion Clinical Trial
Official title:
Dual Source Computed Tomography (DSCT) During Injection of Dipyridamole : a New Technique for Myocardial Ischemia Assessment
The goal of this study is to evaluate the ability of MDCT under stress to assess myocardial ischemia. There is some preliminary data in the literature showing the ability of MDCT under stress to bring relevant information about myocardial ischemia. Stress MDCT will have several advantages over single photon emission computed tomography (SPECT) imaging namely: shorter acquisition time, lower irradiation dose, lower cost. The feasibility of such experiment is still debated and need to be address in a clinical study.
Hypothesis: Cardiac dual source computed tomography (DSCT) performed during dipyridamole
infusion allows for 1) myocardial perfusion analysis and detection of myocardial ischemia
and 2) good quality evaluation (artefact free) of the coronary artery anatomy. Cardiac DSCT
during dipyridamole infusion may assess in a single volume acquisition relevant information
about coronary anatomy and myocardial ischemia that required today two different
examinations each with a cost and side effects. Recently investigators showed on animal
models as well as in humans that MDCT during stress test could detect myocardial ischemia.
Purposes: 1) To evaluate the diagnostic potential sensitivity, specificity of coronary DSCT
during dipyridamole infusion for the assessment of myocardial ischemia with myocardial
single photon emission computed topography (SPECT) as standard of reference. 2) To evaluate
the feasibility (presence of artefact, number of coronary segment assessable) of coronary
DSCT during dipyridamole injection.
Methods: This prospective study will include patients referred from the department of
cardiology of Nord hospital. Inclusion criteria will be: patients who required functional
evaluation of a known coronary artery lesion. Patients will be successively include. Each
patient will undergo myocardial SPECT and coronary DSCT during dipyridamole injection.
Coronary DSCT image analysis will determine the severity and the extension of the ischemic
territory. Statistical analysis will determine the reproductibility of the described
technique, compared the DSCT with SPECT as standard of reference and determined sensitivity,
specificity and predictive values (positive and negative) of the described technique.
;
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02486068 -
ABSORB Bioresorbable Scaffold vs. Xience Metallic Stent for Prevention of Restenosis in Patients at High Risk of Restenosis
|
N/A | |
Not yet recruiting |
NCT06373601 -
SPAGO: Sirolimus Paclitaxel Angiographic Gain Objective
|
N/A |